CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 97 enrolled
Drug / intervention
EsoGuard resultdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05778851
NCT05778851N/ACompleted

Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial

Lucid Diagnostics, Inc.·interventional·Posted Mar 21, 2023·Updated Oct 30, 2025

In Brief

A clinical study evaluating EsoGuard result for Barrett Esophagus. Completed, enrolled 97 participants across 1 site.

Detailed Summary

This will be a prospective randomized, controlled, virtual, patient study to measure the impact of EsoCheck/EsoGuard on health care provider's decision for upper endoscopy referral. The participants will complete two rounds of questions concerning the assessed risk for BE and decision for endoscopy referral of 6 patient cases (clinical vignettes). After the first round has been completed, an EsoCheck/EsoGuard educational information package and the second round of 6 clinical vignettes including EsoGuard results will be sent.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMedex15

Timeline

N/ACompletedFinished
202420252026
First PostedMar 21, 2023
Enrollment StartApr 12, 2023
Primary CompletionJul 31, 2024
Study CompletionAug 19, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.3 years ago

Interventions

EsoGuard resultdevice

Education slide-set EsoGuard and patient cases including EsoGuard result